Dr. Anindya Bagchi
Styx Biotechnologies CEO & Co-founder
Styx is co-founded by four passionate scientists who truly believes in the power of basic research. With pertinent human health problems in mind, our mission is to craft innovative technologies that empower the immune system to deliver lasting cures.
At Styx, we have developed technologies that allow specific reprogramming of immune cells to generate more robust and enduring immune responses. With our pioneering approach, we have remarkably improved the effectiveness of many vaccines
- based interventions. Our disruptive technology is specific, safe, far superior to our competitors’, and is set to transform the global vaccine market.